Breadth versus depth in R&D managementTakeda’s Georgia Keresty is one of the only chief operating officers (COOs) for R&D in the industry. She Share XBreadth versus depth in R&D managementhttps://deep-dive.pharmaphorum.com/magazine/research-and-development-disruption-2020/breadth-versus-depth-in-r-and-d-management/
AstraZeneca on expanding its diabetes research franchiseAstraZeneca is hoping to build a strong focus on cardiovascular, renal, and metabolic (CVRM) diseases. Richard Staines spoke Share XAstraZeneca on expanding its diabetes research franchisehttps://deep-dive.pharmaphorum.com/magazine/research-and-development-disruption-2020/astrazeneca-takes-on-cvrm/
Delivering change through better rare disease communicationsOPEN Health’s Richard Jones, Gemma Allen and Charlotte Richards discuss how pharma can utilise tools, channels and stakeholders Share XDelivering change through better rare disease communicationshttps://deep-dive.pharmaphorum.com/magazine/research-and-development-disruption-2020/delivering-change-through-better-rare-disease-communications/
Bringing social media listening into R&DAfter her daughter was diagnosed with Prader-Willi syndrome, Maria Picone used social media listening and AI analytics to Share XBringing social media listening into R&Dhttps://deep-dive.pharmaphorum.com/magazine/research-and-development-disruption-2020/bringing-social-media-listening-rd/
The power of crowdsourced R&DDrug R&D is still dogged by attrition, duplication and waste. Chas Bountra, chief scientist & head of the Share XThe power of crowdsourced R&Dhttps://deep-dive.pharmaphorum.com/magazine/research-and-development-disruption-2020/crowdsourcing-rd/
An innovative approach to improving research and patient care with NHS dataUnderstanding how patients are treated in routine clinical care has great potential to improve treatment and enrich academic Share XAn innovative approach to improving research and patient care with NHS datahttps://deep-dive.pharmaphorum.com/magazine/research-and-development-disruption-2020/improving-research-patient-care-nhs-data-iqvia/
Staying on the cutting edge of oncology advancesRapidly-changing treatment landscapes in diseases like lung cancer pose challenges for medical education providers, who need to be Share XStaying on the cutting edge of oncology advanceshttps://deep-dive.pharmaphorum.com/magazine/research-and-development-disruption-2020/cutting-edge-oncology-advances-medscape-medical-education/
AI meets human intelligence to address brain healthResearchers agree that early detection is the key to optimising the potential success of drug and device therapies Share XAI meets human intelligence to address brain healthhttps://deep-dive.pharmaphorum.com/magazine/research-and-development-disruption-2020/artificial-intelligence-meets-human-intelligence-to-collaborate-on-addressing-brain-health-parkinsons-nq-medical/
